HYPE: Shatavari naturally balances female hormones and relieves menopause symptoms.
But what does the evidence actually show?
Small placebo-controlled trials report improvements in some menopause symptoms, including hot flushes, and some report hormone changes. That is promising preliminary evidence. It does not establish a reliable, general-purpose hormone-balancing effect, long-term safety or equivalence to established treatments.
Claim assessed: Shatavari root extracts relieve menopause symptoms through a dependable, clinically useful hormone-balancing effect.
Why people believe it
Shatavari is Asparagus racemosus, a plant traditionally used in Ayurveda for women's health. Root extracts contain compounds investigated for oestrogen-related and other biological activity. This offers a research rationale, especially for people seeking options beyond hormone replacement therapy. [1] [2]
However, balance needs a definition. A symptom score improving, one blood hormone increasing and a treatment restoring a healthy hormonal system are different claims. Menopause is a life stage, not evidence that every person needs the same hormone level or the same supplement.
What the early randomised trials show
A 2024 trial randomised 70 women to a Shatavari preparation or placebo for roughly eight weeks. It reported improvements in several symptoms, including hot flushes and sleep-related difficulties. That is more informative than testimonials, but a small, short trial of one extract cannot validate every capsule or gummy. [1]
A 2025 trial randomised 80 women with perimenopausal symptoms; 73 completed it. A standardised 300 mg daily extract produced greater improvements in menopause symptom scores and hot flushes over eight weeks. Some hormone measurements also differed. The investigators acknowledged the short duration and single-site design; an extract supplier provided the study material. [2]
What newer studies add
A separate eight-week, three-arm study enrolled 135 women and compared Shatavari, Shatavari plus ashwagandha, and placebo. The combined preparation showed the clearest reported symptom advantage. Its results should not be attributed entirely to Shatavari alone. The paper reported maintained normal hormonal levels, rather than a universal hormonal reset. [3]
A 2026 placebo-controlled report involving 70 peri- and postmenopausal women tested a different extract at 400 mg daily for 56 days. Its published abstract reports improved symptoms and changes in selected hormones, including oestradiol and luteinising hormone. We assessed the abstract; that limits scrutiny of the complete methods and analyses. [4]
Another 2026 study of the proprietary SheVari4 extract reported symptom and selected hormonal changes over eight weeks. Different extracts and study populations make simple dose comparisons misleading. Its findings add a signal worth checking, rather than proof that every marketed Shatavari product has the same effects. [5]
The important catch: changing a hormone is not proving balance
Hormone findings are not identical across these studies. A statistically significant change does not by itself show that a value was unhealthy beforehand, that the change caused symptom relief, or that it improves long-term health. Some studies combine participants at different menopausal stages, which also complicates interpretation. [2] [3] [4] [5]
Short trials cannot settle uncommon adverse effects or outcomes developing over years. Multiple symptom scales and hormone tests create many opportunities to find a positive result. Independent replication, prespecified analyses and a clear benefit on an outcome that matters to patients would improve confidence. Early positive results deserve neither dismissal nor the certainty of an established therapy.
Safety and established options
The trials generally report reassuring short-term tolerability, but that does not establish safety during prolonged use or for people excluded from the studies. A normal liver test after eight weeks cannot answer every interaction or hormone-sensitive-condition question. [1] [2] [3] [4] [5]
Ask a pharmacist or clinician about the actual preparation if you take medicines, have a hormone-sensitive condition, or are considering combining it with HRT. The NHS advises that herbal menopause products are not assessed and regulated in the same way as medicines, and natural does not guarantee safety. [6]
HRT and appropriate non-hormonal treatments remain options to discuss according to symptoms, medical history and preferences. These Shatavari trials did not establish equivalence to HRT or prove that replacing prescribed treatment would be beneficial. [7]
What this means for you
Start with the symptom you want help with: hot flushes, sleep disruption and vaginal symptoms may need different approaches. If considering Shatavari, ask whether the product matches a studied extract and whether the comparison was against placebo or another treatment. A trial dose describes that preparation; it is not a dose recommendation for all products.
Keep a realistic record of symptoms and discuss persistent or troublesome changes with a clinician. You do not need to choose between taking symptoms seriously and asking careful questions about a supplement.
Promising symptom results deserve further research. Reliable hormone balancing is not clinically established.
Research & Sources
1. Gudise et al. (2024)
Double-blind multicentre randomised trial of Shatavari for menopausal symptoms. Published abstract and methods assessed.
Read the source2. Shatavari root extract for perimenopause (2025)
Randomised trial: 80 allocated, 73 completers, eight weeks. Published results and limitations assessed.
Read the source3. Ademola et al. (2025)
Three-arm trial of Shatavari, Shatavari plus ashwagandha, and placebo. Published abstract and methods assessed.
Read the source4. Babu et al. (2026)
Multicentre placebo-controlled study, 70 participants, 56 days. Published abstract assessed.
Read the source5. SheVari4 proprietary extract trial (2026)
Eight-week placebo comparison with symptom and hormonal outcomes. Published abstract and selected results assessed.
Read the source6. NHS: herbal menopause remedies
Quality, interactions and uncertainty about safety and lasting effects.
Read the source7. NHS: menopause treatment
Established hormonal and non-hormonal treatment options.
Read the sourceEvidence reviewed: October 2026
Targeted editorial review of research available on 23 October 2026, not an exhaustive systematic review. Abstract-only assessments and conference evidence are identified above. Featured artwork is illustrative, not a study result.
Evidence vs Hype explains scientific research for educational purposes and does not provide individual medical diagnosis or treatment.
